IV drug users respond well to endophthalmitis treatment

Intravenous drug users who had endogenous endophthalmitis responded better to treatment than those who did not use drugs, according to a retrospective medical record review.
The researchers said those who did not use drugs fared worse due to more chronic comorbidities and older age.
Investigators chose a large medical center in New Hampshire for its patient population, as the age-related rate of deaths associated with drug use is higher in the state, at 26.2 per 100,000 people, compared to the Northeast regional average of 16.1 per 100,000 people.
During the (Read more...)

Full Story →

IV drug users respond well to endophthalmitis treatment

Intravenous drug users who had endogenous endophthalmitis responded better to treatment than those who did not use drugs, according to a retrospective medical record review.
The researchers said those who did not use drugs fared worse due to more chronic comorbidities and older age.
Investigators chose a large medical center in New Hampshire for its patient population, as the age-related rate of deaths associated with drug use is higher in the state, at 26.2 per 100,000 people, compared to the Northeast regional average of 16.1 per 100,000 people.
During the (Read more...)

Full Story →